Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
Recruiting
Previous studies showed that a dose of 8 millicuries of Altropane was appropriate for imaging patients with suspected Parkinson's disease. This study will determine if a lower dose (5 millicuries) would suffice.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/01/2023
Locations: University of Mississippi Medical Center (UMMC), Jackson, Mississippi
Conditions: Parkinson Disease, Movement Disorders